JS005

· Shanghai Junshi Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for JS005, covering 2022-01-27 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

See pricing